ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1511	National Cancer Institute	Html	en	Small Cell Lung Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of small cell lung cancer.	clinical trial 0.236127 treatment 0.276669 patients 0.200061 Lung Cancer Prevention 0.201183 cancer cells 0.289303 body 0.206914 Lung Cancer Treatment 0.223408	PDQ cancer information 0.202281 cell lung cancer 0.911961 small cell lung 0.946074 radiation therapy 0.266516 National Cancer Institute 0.212636 clinical trials 0.458637 information 0.20384	CLICK HERE
1579	National Cancer Institute	Html	en	Skin Cancer Treatment (PDQ®)–Patient Version	Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common types of skin cancer. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for skin cancer.	general cancer information 0.204481 skin cancer 0.746718 treatment 0.471679 cancer treatment 0.302297 new cancer treatments 0.201272 NCI-supported cancer 0.203834 cancer cells 0.430807 cancer spreads 0.213207 body 0.317841 type 0.211396 actinic keratosis 0.536665 Cancer Information Service 0.206951 PDQ cancer information 0.297384 Mohs micrographic surgery 0.232682 clinical trial search 0.229474 nonmelanoma skin cancers 0.227999 treatment clinical trials 0.229958 National Cancer Institute 0.31726 clinical trials 0.638709 nearby lymph nodes 0.200291	cancer information summary 0.262865 clinical trial 0.388191 new treatment 0.294947 Skin Cancer Treatment 0.245684 abnormal cells 0.206059 metastatic skin cancer 0.238791 metastatic tumor 0.203344 NCI PDQ cancer 0.214553 Treatment Option Overview 0.208332 cancer clinical trials 0.26868 stage 0.23544 tumor 0.379395 lymph node 0.25053 radiation therapy 0.273121 cancer information summaries 0.204643 nonmelanoma skin cancer 0.66985 comprehensive cancer information 0.204409 basal cell carcinoma 0.71551 cancer 0.986958 information 0.320731	CLICK HERE
1607	National Cancer Institute	Html	en	Levels of Evidence for Cancer Screening and Prevention Studies (PDQ®)–Health Professional Version	Information about how to weigh the strength of the evidence obtained in cancer screening and prevention research studies.	highly selected populations 0.401378 evidence 0.991311 health problem 0.419092 ovarian cancer results 0.40408 PDQ cancer information 0.513684 preventive service 0.422639 PDQ information 0.400135 harms 0.473049 PDQ Editorial Board 0.641716 cancer information summary 0.473744 breast cancer prevention 0.40374 overall mortality reduction 0.492575 potential benefits 0.414509 level 0.4235 evidence support 0.537413 overall evidence 0.50904 NCI’s PDQ 0.403183 quality 0.384284 NCI PDQ cancer 0.45235 reduced usual activity 0.399404 mortality effect 0.425411 intervention 0.453795 health effects 0.479173 Editorial Board 0.827603	benefits 0.440799 clear determination 0.42011 all-cause mortality question 0.432333 general population 0.48479 potential harms 0.397031 conceptual confidence interval 0.402548 health important degree 0.511077 actual evidence 0.562605 specific harms 0.394046 National Cancer Institute 0.475921 magnitude 0.455969 important health effects 0.420577 reasonably certain estimate 0.435178 PDQ documents 0.402929 pdq screening 0.511986 public health 0.419028 direction 0.390004 actual health impact 0.418321 question 0.457086 indirect evidence 0.492584 disease-specific reduction 0.408785 Prevention Editorial Board 0.514271 Alternative format 0.424205 efficacy evidence 0.51812	CLICK HERE
1701	National Cancer Institute	Html	en	Pathology Reports	A fact sheet describing the information found in a pathology report, the document that contains results of the examination of tissue removed during biopsy or surgery.	NCI-designated cancer centers 0.497751 technical medical language 0.492686 pathology report 0.906587 certain noncancerous conditions 0.486594 pathology results 0.507902 tissue 0.71912 Pathology reports 0.571018 cancer cells 0.487918 malignant cells 0.475383 Cancer Information Service 0.505692 microscope 0.502866 ) sections. 0.523472 different cancer types 0.498063 frozen section 0.50145 naked eye 0.506619 permanent) sections. 0.503784 clinical trials 0.546491 flow cytometry 0.487161 tumor cells 0.49749 normal cells 0.47705 particular DNA sequence 0.477991 entire tumor 0.507705 tumor markers 0.496268	tissue culture 0.501671 tissue sample 0.575447 chronic myelogenous leukemia 0.479887 diagnosis 0.476227 normal tissue 0.5122 pathology laboratory 0.521862 tissue samples 0.511673 frozen sections 0.490304 clinical trials page 0.487126 particular DNA sequences 0.478454 Polymerase chain reaction 0.483064 Western blot hybridization 0.484206 cells 0.582619 tissue firm 0.512918 biopsy date 0.47785 live cells 0.477142 gross description 0.504759 biopsy 0.507407 particularly genetic alterations 0.48591 information 0.537969 cancer 0.518713 pathologist 0.518021 pathology specimens 0.507289	CLICK HERE
1778	National Cancer Institute	Html	es	Delirium (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del delirium como una complicación del cáncer o su tratamiento. Se discuten los abordajes de los cuidados médicos de apoyo, así como farmacológicos para el manejo del delirium.	delirium rating 0.635037 Cancer Res Clin 0.330668 Breitbart W 0.391378 recognizing delirium 0.408363 Misdiagnosing delirium 0.408657 Sin embargo 0.38098 delirium among elderly 0.415971 Fainsinger RL 0.329645 Lipowski ZJ 0.334677 Gagnon B 0.354723 Predicting delirium 0.41556 risk factors 0.327409 Delirium Assessment Scale 0.517982 Delirium risk 0.412345 Delirium presenting with 0.419293 patients with delirium 0.445355 Natl Cancer Inst 0.328774 antipsicóticos típicos 0.342502 McCallion J 0.33665 Lawlor PG 0.511955 término delirium 0.437321 Neuropsychiatry Clin Neurosci 0.328992 Mancini IL 0.351836 hospitalized patients with 0.376004 específica cuáles pacientes 0.32777	Palliat Care 0.338189 patients with 0.960984 Pain Symptom Manage 0.86069 prevent delirium 0.429024 Miller L 0.327272 American Psychiatric Association 0.3525 bedside confusion scale 0.336758 Care Cancer 0.332558 palliative care 0.358676 hospitalized elderly 0.35987 Memorial Delirium Assessment 0.513933 Delirium after 0.413891 Intern Med 0.666809 delirium rating scale-revised-98 0.51332 confusion assessment method 0.339276 Clin Oncol 0.334335 Arch Intern Med 0.574627 Bruera E 0.37373 with adjuvant 0.332147 elderly patient 0.402747 terminal delirium 0.422735 antipsicóticos atípicos 0.439946 prospective study 0.581043 Inouye SK 0.47182	CLICK HERE
1905	National Cancer Institute	Html	es	Tratamiento del cáncer de hígado infantil (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de hígado infantil.	grupo iii 0.507215 siguientes procedimientos 0.435845 grupo posttext 0.428004 efectos secundarios meses 0.436827 cuáles secciones 0.430744 pequeña cantidad 0.417301 grupos pretext 0.622136 grupo pretext 0.494022 rayos x 0.426417 niño ayuda 0.426517 grupo ii 0.508034 cuerpo usa 0.472879 ondas sonoras 0.42867 efectos tardíos 0.57237 PDQ Efectos tardíos 0.457898 National Cancer Institute 0.41066 IRMN).Ampliar Imágenes 0.423392	microesferas minúsculas 0.417674 Instituto Nacional 0.442931 PDQ Tratamiento 0.80031 determinados cambios 0.489668 características histológicas 0.903803 nuevos tipos 0.420467 grupo iv 0.455083 distintos tipos 0.457348 Physician Data Query 0.443332 Estados Unidos 0.431258 siguientes situaciones 0.427998 abdomen.ampliar exploración 0.426559 siguientes enlaces 0.410964 altas concentraciones 0.429265 sanguíneos principales.ampliar ecografía 0.456159 siguientes trastornos 0.423684	CLICK HERE
3459	National Cancer Institute	Html	es	Coenzima Q10 (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de la conzima Q10 como tratamiento para las personas con cáncer.	Centro Nacional 0.333125 Vitamina Q10 0.341732 New Hampshire Avenue 0.323053 Drug Administration 0.314317 leucemia linfoblástica aguda 0.341078 NCI Best Case 0.342133 vía oral 0.324149 mejores pruebas 0.318969 datos bibliográficos pubmed 0.324983 siguientes preguntas 0.314202 mayores cantidades 0.322901 Premio Nobel 0.323381 siguientes riesgos 0.318032 máximo nivel 0.322444 seguro médico 0.313926 Instituto Nacional 0.428917 vitamina e 0.322593 conzima q10 0.331342 Salud Complementaria 0.35167	Visuals Online 0.317138 complementarias revisa 0.324022 daños causados​por 0.322061 Physician Data Query 0.399292 coenzima q10 0.631002 Estados Unidos 0.532938 cáncer doxorrubicina 0.420236 antraciclina doxorrubicina 0.326213 libre uso 0.31803 página manejo 0.315983 ¿El tratamiento 0.336183 ¿Los beneficios 0.314951 CoQ10 ayuda 0.788819 cuerpo elabora 0.394571 coenzima ayuda 0.33485 Series Program 0.314402 medicina complementaria 0.970585 siguientes deficiencias 0.324091	CLICK HERE
3856	National Cancer Institute	Html	en	Christal Sohl, Ph.D.	The San Diego State University biologist uses a variety of methods, including structural, computational, and kinetic analyses, to study enzymes that may play a role in cancer.	personal time 0.583145 polymerase enzymes 0.576932 isocitrate dehydrogenase 0.57565 environmental pollutants 0.576985 Fred Guengerich 0.587519 cell growth 0.572096 K99/R00 grant application 0.63899 job applications 0.56948 generous people 0.568794 enzyme structure 0.620541 mutated conditions 0.575037 cancer-promoting metabolite 0.574359 Diego State University 0.633881 graduate school 0.57248 single point mutation 0.637959 research career 0.583765 strong mentoring relationships 0.632479 biological substrate 0.582981 daunting prospect 0.569185 enzyme functions 0.618027 Dr. Guengerich 0.599167 tumor-suppressing effects 0.571078 brand-new assistant professor 0.63038 clinically relevant problem 0.636226 research goal 0.576225	SDSU students 0.573824 postdoc Dr 0.580928 kinases—cellular signaling proteins 0.631824 Vanderbilt University 0.576153 cancer drugs 0.568875 R01 grant 0.59259 human disease 0.573514 K99/R00 grant 0.703102 George Richter-Addo 0.576773 undergraduate biochemistry course 0.648526 Yale University 0.573003 enzyme kinetics—the study 0.706771 earlier career stages 0.620329 enzymatic reaction 0.574931 inaccurate DNA replication 0.627233 assistant professor 0.762524 Karen Anderson 0.570977 K99/R00 transition grant 0.643727 Dr. Sohl 0.961111 hard work 0.580209 enzyme kinetics—and 0.636377 single step 0.57426 DNA strands 0.56849 Christal Sohl 0.703616	CLICK HERE
3887	National Cancer Institute	Html	en	Childhood Vascular Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood vascular tumors.	steroid-dependent infantile hemangiomas 0.300343 Arch Dermatol 0.314605 infantile hemangiomas 0.901693 significant infantile hemangiomas 0.320133 PUBMED Abstract 0.753846 phace syndrome 0.226305 infantile cutaneous hemangiomas 0.345917 superficial infantile hemangiomas 0.313373 congenital hemangioma 0.28169 infantile haemangiomas 0.234409 infantile hepatic hemangiomas 0.307672 compound infantile hemangiomas 0.306324 Severe Infantile Hemangioma 0.319287	lobular capillary hemangioma 0.22126 hemangioma endothelial cells 0.221846 Infantile hemangioma proliferation 0.38483 Mixed Infantile Hemangiomas 0.309771 vascular tumors 0.21682 Br J Dermatol 0.208054 Pediatr Dermatol 0.504488 Drolet BA 0.2263 cutaneous infantile hemangiomas 0.372661 infantile hemangioma 0.981205 human infantile hemangioma 0.349661 et al. 0.68661	CLICK HERE
15671	National Cancer Institute	Html	en	National Cancer Institute Overview and Mission	Learn about the National Cancer Institute and what we do, our impact, and our future plans.	NCI Budget Fact 0.497121 federally funded research 0.465442 research education 0.373076 cancer deaths 0.368559 research efforts 0.378749 clinical trial sites 0.42553 improved cancer treatments 0.481082 new cancer cases 0.455562 private-sector life sciences 0.407381 research career development 0.478109 clinical trials 0.413733 publicly available cancer 0.474225 National Institutes 0.330098 cancer patients 0.381628 research laboratories 0.378804 comprehensive training programs 0.420146 NCI 0.551669 clinical research 0.391338 cancer survivors 0.364801 training opportunities 0.416201 intramural training programs 0.437578 National Cancer Program 0.503712 career development opportunities 0.414542 Funds training 0.333548 advanced technology development 0.398899	Maintains long-term storage 0.390918 cancer prevention 0.393108 United States 0.478805 training grants 0.329153 cancer research 0.942525 private philanthropic organizations 0.403666 scientific knowledge 0.423431 cancer research disciplines 0.531444 various research programs 0.452562 National Cancer Institute 0.528313 NCI laboratories 0.431835 cancer researchers 0.38535 research institutions 0.37224 Supports intramural research 0.523044 innovative laboratory research 0.451762 Frederick National Laboratory 0.407026 cancer detection 0.370327 NCI’s expenditures 0.416543 career development 0.479695 cancer care delivery 0.459112 biomedical research 0.373736 cancer research enterprise 0.566317 NCI’s laboratories 0.427372 NCI-Designated Cancer Centers 0.493446	CLICK HERE